Multi-omics Merge for Ensemble Subtyping for Atherosclerotic Cardiovascular Disease and Related Mechanism Study

The biological mechanisms driving the progression of coronary artery disease (CAD) are complex and multifaceted. While there have been significant advances in understanding these mechanisms, much of the biological evidence remains limited and fragmented, especially beyond the realms of metabolomics and microbiomics. For instance, the detailed histologic mapping of the deterioration of coronary atherosclerosis still requires more extensive clinical and basic research to substantiate initial findings.

To address these gaps, researchers are turning to comprehensive analyses of clinical and multi-omics data from patients with coronary heart disease. This involves a deep dive into various data types, including genomics, proteomics, metabolomics, and microbiomics, to identify potential risk factors associated with CAD. By integrating these data, investigators aim to uncover molecular subtypes of the disease that can provide a more nuanced understanding of its progression.

Furthermore, the goal is to develop robust prognostic prediction models that can accurately forecast the risk of CAD in individual patients. These models will leverage the identified molecular subtypes and associated risk factors to offer personalized predictions, which are crucial for effective clinical decision-making. Through this individualized approach, it will be possible to enhance the screening processes for high-risk groups and design more precise and effective intervention strategies.

Ultimately, this research endeavors to bridge the gap between basic scientific discoveries and clinical applications, paving the way for tailored therapeutic interventions that can significantly improve patient outcomes in coronary artery disease.